Swiss pharma major Novartis has reported that its oral candidate remibrutinib significantly cut relapse rates against French ...

French biotech firm Inventiva (Euronext: IVA) has appointed Chris Benecchi as chief operating officer, completing its ...

Medicines regulators in major international markets have issued a run of first-in-class approvals, safety communications, ...

US biotech major Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk adults ...

Sino-American oncology-focused biotech BeOne Medicines has announced positive top-line results from the second interim ...

Immunic, a late-stage biotech developing oral therapies for neurological diseases, has appointed Chitrang Davé as chief data ...

Swiss pharma giant Novartis said its Phase III REMODEL-1 and REMODEL-2 trials of remibrutinib met their primary endpoint, ...

The White House has announced that nine additional pharmaceutical manufacturers have signed most-favored-nation (MFN) pricing ...

RedHill Biopharma today announced the transformational acquisition of exclusive global and US commercialization rights to ...

US pharma major Eli Lilly is continuing its streak of M&A activity, inking an agreement to acquire Merida Biosciences, a ...

The 2026 theme is "Data to Dialogue: Communicating Radiotherapy's Value to Advance Care". The 68th annual meeting runs from ...

Waltham, Massachusetts-based advanced therapy contract development and manufacturing organization (CDMO) and gene editing ...